Aronson Martha Goldberg 4

What Happened

Martha Goldberg Aronson, President, CEO and a director of Merit Medical Systems, was granted 28,198 restricted stock units (RSUs) on February 26, 2026. The RSUs were awarded at a $0.00 per-share price (no cash paid) and represent the contingent right to receive one share of Merit Medical common stock per RSU upon vesting.

This is a compensation award (not an open-market purchase or sale) and is routine for executive pay. It does not represent an immediate sale or purchase of shares on the market.

Key Details

• Transaction date: 2026-02-26; reported on Form 4 filed 2026-03-02 (filed within the standard reporting window).
• Award: 28,198 RSUs granted; price recorded $0.00 (no cash exchanged).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service. Each RSU equals the contingent right to one share upon vesting. (See footnote F1.)
• No 10b5-1 plan, tax-withholding sale, or immediate cashless exercise noted in the supplied data.

Context

RSU grants are a common form of long-term compensation for executives and are intended to align management with shareholder interests over time. Because these RSUs vest over three years and require continued service, they represent future potential stock issuance rather than an immediate market transaction and should not be interpreted alone as a bullish or bearish signal.